FDA Designates MM120 (LSD) Breakthrough Therapy for Generalized Anxiety Disorderhttps://www.businesswire.com/news/home/20240307733599/en/MindMed-Receives-FDA-Breakthrough-Therapy-Designation-and-Announces-Positive-12-Week-Durability-Data-From-Phase-2B-Study-of-MM120-for-Generalized-Anxiety-Disorder by beefman • 2 years ago 122 64 2 years agoBUbusinesswire.com